(December 5, 2018, 11:30 AM EST) -- WASHINGTON, D.C. — The U.S. solicitor general on Nov. 30 urged the U.S. Supreme Court not to review a federal circuit court ruling that sent a whistleblower case against HIV drug maker Gilead Sciences back to a federal district court (Gilead Sciences, Inc. v. United States ex rel. Jeffrey Campie, et al., No. 17-936, U.S. Sup.)....